While hs-cTnI above the limit of detection conferred an increased risk of the composite outcome in patients with CLTI when considering only the clinical presentation of PAD and biomarker values, its prognostic performance was lost after adjusting for clinical characteristics and common cardiovascular risk factors. Here, TNNI3 is linked to peripheral arterial disease.